SCHEMBL24755709

SCHEMBL24755709

Nc1cncc(C(=O)N2CCC2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.61
▸ ALDH1A1 P00352 3/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ DDO Q99489 1/20 0.55
▸ L3MBTL4 Q8NA19 1/20 0.47
▸ L3MBTL3 Q96JM7 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ HSD11B1 P28845 1/20 0.46
▸ HPGD P15428 3/20 0.46
▸ CYP11B2 P19099 2/20 0.45
▸ CYP11B1 P15538 1/20 0.44
▸ HRH3 Q9Y5N1 2/20 0.43
▸ PKM P14618 1/20 0.42
▸ DPP4 P27487 1/20 0.42
▸ DPP8 Q6V1X1 1/20 0.42
▸ DPP7 Q9UHL4 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ BTK Q06187 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30933132 1.00 KDM4E (0.61) KDM4EALDH1A1MEN1LMNAKMT2A
SCHEMBL18041382 0.97 KDM4E (0.66) KDM4EALDH1A1MEN1LMNAKMT2A
SCHEMBL3400117 0.85 SMN1; SMN2 (0.54) KDM4EALDH1A1MEN1LMNAKMT2A
SCHEMBL13279929 0.81 ALDH1A1 (0.48) KDM4EALDH1A1MEN1LMNAKMT2A
SCHEMBL1964003 0.79 L3MBTL4 (0.69) KDM4EALDH1A1MEN1LMNAKMT2A
SCHEMBL14731492 0.79 KDM4E (0.46) KDM4EALDH1A1MEN1LMNAKMT2A
SCHEMBL24756635 0.78 MEN1 (0.51) KDM4EALDH1A1MEN1LMNAKMT2A
SCHEMBL29224884 0.76 HRH3 (0.50) KDM4EALDH1A1MEN1KMT2AL3MBTL4
SCHEMBL18376152 0.76 HPGD (0.64) KDM4EALDH1A1KMT2AL3MBTL4L3MBTL3
SCHEMBL14991641 0.76 L3MBTL3 (0.74) KDM4EALDH1A1MEN1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022265993-A1 UREA DERIVATIVES WHICH CAN BE USED TO TREAT CANCER SCORPION THERAPEUTICS, INC. (US) 2022-12-22 — — WO disclosed
Send feedback